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a b s t r a c t
Calpains are a family of calcium-dependent intracellular cysteine proteases that regulate several
physiological processes by limited cleavage of different substrates. The role of Calpain2 in embryogenesis
is not clear with conﬂicting evidence from a number of mouse knockouts. Here we report the temporal
and spatial expression of Calpain2 in Xenopus laevis embryos and address its role in Xenopus
development. We show that Calpain2 is expressed maternally with elevated expression in neural tissues
and that Calpain2 activity is spatially and temporally regulated. Using a Calpain inhibitor, a dominant
negative and a morpholino oligonoucleotide we demonstrate that impaired Calpain2 activity results in
defective convergent extension both in mesodermal and neural tissues. Speciﬁcally, Calpain2 down-
regulation results in loss of tissue polarity and blockage of mediolateral intercalation in Keller explants
without affecting adherens junction turnover. We further show that Calpain2 is activated in response to
Wnt5a and that the inhibitory effect of Wnt5a expression on animal cap elongation can be rescued by
blocking Calpain2 function. This suggests that Calpain2 activity needs to be tightly regulated during
convergent extension. Finally we show that expression of Xdd1 blocks the membrane translocation of
Calpain2 suggesting that Calpain2 activation is downstream of Dishevelled. Overall our data show that
Calpain2 activation through the Wnt/Ca2þ pathway and Dishevelled can modulate convergent extension
movements.
& 2013 The Authors. Published by Elsevier Inc.
Introduction
Calpains are a family of calcium-dependent intracellular cysteine
proteases that regulate several physiological processes (i.e. signal
transduction, cell proliferation, apoptosis and cell motility) via precise
and limited cleavage of speciﬁc proteins (Wells et al., 2005). Dereg-
ulation of speciﬁc Calpain activities have been implicated in numerous
pathological conditions, including cancer, Alzheimer's disease, type
2 diabetes and muscular dystrophy. Among the 14 members of the
Calpain family, the two ubiquitous isoforms Calpain1 (or m-Calpain)
and Calpain2 (or m-Calpain) are the most studied. They are hetero-
dimers composed of a large catalytic subunit of 80 kDa and a common
regulatory subunit of 30 kDa (Calpain4) that dissociates upon activa-
tion. Calpain1 and Calpain2 share 61% of sequence identity and
are very similar in substrate speciﬁcity and subcellular localisation
but they require different Ca2þ concentrations for their activity,
10–50 mM and 4500 mM respectively. These concentrations are
considerably higher than physiological intracellular concentrations
of Ca2þ (usually o1 mM), suggesting the presence of regulatory
mechanisms that may lower this requirement. Indeed Calpain2
binds to phospholipids (particularly phosphoinositide biphosphate,
PIP2) (Leloup et al., 2010) and thus localises at the membrane
close to its substrates/cofactors and calcium channels. The role of
Calpains in cell migration has been extensively investigated in vitro.
Various substrates of Calpains are found in adhesion complexes
(i.e. talin, paxillin, focal adhesion kinase, E-cadherin and the
cytosolic tails of some β-integrins) (Wells et al., 2005). However,
the study of Calpain function in vivo is still in its infancy. While
knockout of Calpain1 resulted in fertile mice with a reduction in
platelet aggregation (Azam et al., 2001), disruption of Calpain2 gene
in mice led to early embryonic lethality prior to the implantation
stage and lack of embryos beyond the 8-cell stage, suggesting that
Calpain2 activity is essential for cell viability (Dutt et al., 2006). This
is also consistent with another study showing that mice deﬁcient
for the regulatory subunit Calpain4 also died prior to the implanta-
tion stage (Zimmerman et al., 2000). Interestingly, in a separate
study where Calpain4 was targeted with a hypomorphic mutation
(possibly retaining some basal level of activity) the mice survived to
mid-gestation by which time they died due to a failure in heart
morphogenesis (Arthur et al., 2000). However, a later study showed
that Calpain2 was in fact only required in extraembryonic tissues
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during mouse development since a fetus-speciﬁc conditional Cal-
pain2 knockout resulted in nearly half of the mice surviving to
adulthood without any signiﬁcant abnormalities (Takano et al.,
2011). In Xenopus, the tissue-speciﬁc Calpain8, previously detected
in smooth muscle cells in adult tissues of the rat (Sorimachi et al.,
1993), has been identiﬁed and suggested to be involved in con-
vergent extension movements (Cao et al., 2001) and in neural crest
migration (Cousin et al., 2011). Calpain1 and Calpain2 genes have
also been identiﬁed and sequenced in Xenopus (Klein et al., 2002)
but their function has not yet been investigated.
Mesoderm migration and convergent extension are the major
driving forces in determining the process of gastrulation, neurula-
tion and the formation of the primary body axes during Xenopus
laevis development (Keller, 1986). During gastrulation, the head
mesoderm involutes at the blastopore lip and migrates on the
inner surface of the blastocoel roof towards the animal pole
(mesoderm migration) (Keller et al., 2003). As they involute,
mesodermal cells also converge toward the dorsal midline (con-
vergence), and at the same time elongate along the future
anterior–posterior axis (extension). These movements contribute
both to blastopore closure and body axis elongation (Keller et al.,
2008; Wallingford et al., 2002). During neurulation, the presump-
tive posterior hindbrain and spinal cord undergo convergent
extension movements in parallel with those occurring in the
underlying mesoderm. Nevertheless, it has been shown that
neural convergent extension is not a passive but rather an active,
autonomous morphogenetic process resulting from intercalation
of neural ectodermal cells (Elul et al., 1997; Keller et al., 1992; Elul
and Keller, 2000; Wallingford et al., 2002).
Mesoderm and neural convergent extension movements are
regulated by a non-canonical Wnt pathway, known as the planar
cell polarity (PCP) pathway (Habas et al., 2001; Keller et al., 1985;
Wallingford et al., 2002). The PCP pathway modulates the assem-
bly of the actin cytoskeleton and deﬁnes distinct cell polarity, thus
promoting directional cell intercalation.
Although numerous genes that regulate Wnt/PCP signalling have
been identiﬁed (Dsh, JNK, Rho family of GTPases) (Habas et al., 2001;
Yamanaka et al., 2002; Wallingford et al., 2002), the exact mechanism
by which the signal is transduced are still not fully understood.
Calcium signalling (through the Wnt/Ca2þ pathway or in the form
of calcium waves) has also been implicated in convergent extension
movements during both Xenopus gastrulation and neurulation (Kuhl
et al., 2000a, 2000b; Sheldahl et al., 1999; Slusarski et al., 1997a,
1997b). Different molecules that are calcium regulated have been
shown to inﬂuence these movements and a cross-talk between
calcium signalling and the PCP pathway has been identiﬁed at
different levels (Elul and Keller, 2000; Elul et al., 1997; Ezin et al.,
2003; Sheldahl et al., 2003; Shih and Keller, 1992a). In the present
study, we investigate the function of the calcium-dependent protease
Calpain2 during Xenopus gastrulation and neurulation using several
approaches (inhibitor, dominant negative and morpholino oligonu-
cleotide). We demonstrate that Calpain2 expression and activity are
under strict spatiotemporal regulation and that Calpain2 is important
for mesoderm migration and convergent extension of both neural and
mesodermal tissues. We further show that Wnt5a leads to activation
of Calpain2 which in turn is required for convergent extension
movements. Our results suggest that Calpain2 modulates convergent
extension by regulating cell shape and cell polarity.
Materials and methods
Embryo injections and manipulations
Female adult X. laevis frogs were induced to ovulate by injection
of human chorionic gonadotropin. Eggs were fertilised in vitro,
dejellied in 2% cysteine (pH 7.8) and subsequently reared in 0.1
Marc's Modiﬁed Ringers (MMR) and staged according to Neiuw-
koop and Faber (1994). For microinjections, embryos were placed in
a solution of 4% Ficoll in 0.33 MMR and injected using a glass
capillary pulled needle, forceps, a Singer Instruments MK1 micro-
manipulator and Harvard Apparatus pressure injector. After injec-
tions, embryos were reared for 2 h or until stage 8 in 4% Ficoll in
0.33 MMR and thenwashed and maintained in 0.1 MMR alone.
Capped mRNA was in vitro transcribed using mMessage machine
kits (Ambion). 50–100 μΜ Calpain Inhibitor III, CI3, (Millipore) in
0.1 MMR was added to the embryos at different time of devel-
opments for phenotype characterisation. In rescued experiments,
the media containing CI3 was replaced with fresh 0.1 MMR.
DNA constructs and morpholino oligonucleotide
All plasmids were constructed using standard molecular biology
techniques and their sequence was veriﬁed by DNA sequencing.
All primers used are listed in Table S1 in Supplementary information.
Brieﬂy, HA-tagged Calpain2 construct used in rescued experiments
(Capn2R) was generated by polymerase chain reaction (PCR) using
Xenopus Calpain2 Pcmv-sport6 vector (Imagenes) as a template and
Capn2resF and Capn2HAR as primers. Capn2resF primer was
designed starting from the ATG (and thus lacking the 5′UTR region
recognised by the morpholino) and it also includes silent mutations
in the coding sequence (shown in bold in Table S1). Capn2HAR
primer includes the sequence encoding for a C-terminal HA tag. The
PCR product was then cloned into the NotI and XhoI sites of pCS108
vector. HA-tagged Calpain2 construct (including 5′UTR) used for
testing the morpholino effectiveness was generated as above, using
Capn2surF and Capn2HAR as primers. A second HA tag was inserted
in both Capn2R and Calpain2 constructs by site directed mutagenesis
using Capn2insHAF and Capn2insHAR primers. To create Calpain2
dominant negative construct (Capn2C105S) the mutation C105S was
introduced by site directed mutagenesis, using Capn2R pCS108 as a
template and Capn2C105SF and Capn2C105SR as primers. The
Wnt5ASP64T vector was a kind gift from Dr. Chenbei Chang and
was generated as previously described (Moon et al., 1993). The pc52-
mycXdd1 was a kind gift from Dr. John Wallingford.
FITC-Capn2 antisense morpholino (MO) and general control
morpholino were obtained from Gene Tools. The sequence of
Calpain2 MO is GTCTGTCGGCGACCCCGCTCATGTC. The MO was
designed to anneal to a region of Calpain2 mRNA that is not
conserved among the other members of the Calpains family.
RT-PCR
cDNA was prepared via reverse transcription (SuperScriptIII
First strand synthesis, Invitrogen) from RNA extracted (using
standard protocol) from X. laevis embryos. Calpain2 primers
Capn2RTF and Capn2RTR (listed in Table S1) were designed to
anneal to a region of Calpain2 mRNA that is not conserved in the
other members of the Calpain family.
Western blotting and casein zymography
Protein lysates were prepared by homogenising embryos in ice
cold MK's modiﬁed lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl,
0.5%NP-40, 0.5% Triton-X100, 100 mM EGTA, 5 mM NaF) supple-
mented with protease inhibitors. Embryos were homogenised by
pipetting up and down. Lysates were then cleared by centrifuga-
tion at 15,000g for 15–30 min at 4 1C. Total protein content was
quantiﬁed by BCA assay (Sigma). 10–40 mg of lysate were run on a
7.5% SDS-page gel and blotted onto a PVDF membrane. Blots were
then blocked in 5% milk in TBSTw (1 TBS bufferþ0.1%Tween-20)
and incubated with primary antibodies in 2% milk overnight at
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4 1C. Antibodies used: rabbit polyclonal Anti-HA (1:500–1000,
Santa Cruz Biotechnology), mouse monoclonal Anti-actin (1:500
Hybridoma Bank). HRP-conjugated anti-mouse/rabbit/goat (Santa
Cruz Biotechnology) were used as secondary antibodies and
detected using the Lumisensor chemiluminescent reagent kit
(Genscript).
Casein zymography was performed on Xenopus protein extracts
as previously described (Raser et al., 1995) with minor modiﬁca-
tions. Brieﬂy, the non-denaturing casein polyacylamide gels were
pre-run 30 min on ice. Lysates were loaded into the gel and run for
1.5 h at 130 V on ice. Afterwards, the gel was incubated at RT in
calpain activation buffer containing 1–4 mM calcium and 10 mM
dithiothreitol O/N. For negative control, the gel was incubated in
the same buffer without calcium and with the addition of 1 mM
EDTA. Finally the gel was stained with Coomassie blue.
Immunoﬂuorescence
Whole-mount immunoﬂuorescence analysis was carried out as
previously described (Stylianou and Skourides, 2009). Primary
Fig. 1. Calpain2 temporal and spatial expression patterns during Xenopus development. (A) RT-PCR was performed using speciﬁc primers for Calpain2 at different stages of
development. Actin was used as a loading control. (B) Casein zymography analysis was performed as described under Materials and Methods and shows the activity of
Calpain1 (upper band) and Calpain2 (lower band) at different stages of development (left top gel). Western blot of actin was used as a loading control (left bottom gel).
Various amounts (10–40 mg) of whole-embryo lysates were loaded on to the gel to assess the method sensitivity (middle gel). As a negative control, a gel loaded with 20 mg of
lysate was incubated in a noncalcium proteolysis buffer containing 1 mM EDTA (right gel). (C) HA-Calpain2 localisation. (I) Cross-section through the dorsal mesoderm of a
stage 12 embryo ectopically expressing HA-Calpain2 and stained with an anti-HA antibody. A high-magniﬁcation view of the boxed region is shown in the inset. The white
arrow indicates the presumptive Golgi–ER complex. (II) HA-Calpain2 localisation in ectodermal cells of a stage 9 embryo. (III) HA-Calpain2 localisation in neural ectodermal
cells of a stage 13 embryo. Scale bars¼20 μΜ. (D–K) Expression pattern of Calpain2 in Xenopus by WISH. (D) Animal (left) and vegetal (right) view of a stage 5 embryo.
Control hybridisation with the sense probe is shown in the inset. (E) Animal (left) and vegetal (right) view of a stage 9 embryo. Control hybridisation with the sense probe is
shown in the inset. (F) Sagittal section of a stage 10.5 embryo, apical to the top, dorsal to the left. Black arrow: blastopore lip. White arrows: Mesodermal staining. (G) Dorsal
view of a stage 17 embryo, anterior to the bottom. (H) Dorsal (left) and lateral (right) view of a stage 22 embryo, anterior to the bottom. (I–K) Stage 30 embryos. (I) Lateral
view, anterior to the left, dorsal to the top. Control hybridisation with the sense probe is shown in the inset. (J) High magniﬁcation view of anterior region. (K) Cross-section
view, dorsal to the top, of a WISH-stained tailbud embryo visualised by ﬂuorescent microscopy (WISH-staining in red; background ﬂuorescence in green). Abbreviations: e,
eye; ov, optic vescicle; bc, branchial arches; so, somites; no, notochord; nt, neural tube.
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antibodies used: rabbit polyclonal Anti-HA (1:500–1000 Santa
Cruz Biotechnology), rabbit polyclonal or mouse monoclonal
Anti-GFP (1:500–1000 Invitrogen), mouse monoclonal Anti-C-
cadherin (1:300–1:500 Hybridoma Bank). Embryos were incu-
bated with the speciﬁc primary antibody for 4 h at RT or overnight
at 4 1C. Secondary antibodies used: Anti-rabbit alexa 488 (Invitro-
gen, 1:500–1000), Anti-rabbit Cy3 (1:500), Anti-mouse alexa 488
(Invitrogen, 1:500–1:1000). Embryos were imaged on a Zeiss LSM
710 laser scanning confocal microscope and Zen 2010 software or
a Zeiss Axio Imager Z1 using a Zeiss Axiocam MR3, the Axiovision
software 4.8.2.
Whole-mount in situ hybridisation
Whole-mount in situ hybridisation of Xenopus embryos was
performed as previously described (Smith and Harland, 1991).
Probes used were: xBra, Sox2, Chrd, Pax3, Capn2. Capn2 probe was
designed in order to recognise a region of Calpain2 mRNA that is
not conserved in the other members of the Calpain family. The
primers used for the generation of Capn2 probe are listed in Table
S1. Bright ﬁeld images were captured on a Zeiss LumarV12
ﬂuorescent stereomicroscope. For ﬂuorescent WISH images, BM
purple precipitates were detected using customised ﬁlter sets with
excitation between 365 and 465 nm and emission from 795 nm on
a Zeiss Axio Imager Z1 microscope.
Mesoderm convergent extension and radial intercalation
Ectodermal explants (animal caps) were prepared as described
by Wallingford and Harland (2001). To induce mesodermal con-
vergent extension, ectodermal explants were incubated in 10 ng/
ml of human recombinant Activin (Sigma), in the absence or
presence of 50–100 μΜ CI3.
For open-faced Keller explants, embryos were injected dorsally
and animally at four-cell stage with membrane GFP (mGFP) as a
lineage tracer. Explants were excised from stage 10.5 embryos as
previously described (Shih and Keller, 1992b) and cultured in
Danilchik's medium (DFA: 53 mM NaCl, 32 mM sodium gluconate,
4.5 mM potassium gluconate, 1 mM CaCl2, 1 mM MgSO4, 5 mM
Na2CO3, buffered to pH 8.3 with bicine). Inhibitor treated explants
were incubated with 50 μΜ CI3 in DFA.
For radial intercalation, Keller explants were excised at stage
10.5 and plated into coverslips coated with 0.1 mg/ml ﬁbronectin
(Sigma) in DFA in the absence or presence of 50 μΜ CI3.
Neural convergent extension
For animal cap assay, 500 pg of XBF2 (Mariani and Harland, 1998)
were injected in the animal pole of one cell stage embryos. Animal
caps were cut at stage 9 and cultured to stage 20 in DFA medium.
To assess neural convergent extension in the neural plate,
embryos were cultured until stage12–12.5 and explants were
prepared as previously described (Borchers et al., 2006). Following
explants elongation, ΔL was calculated as previously described
(Borchers et al., 2006).
Mesoderm migration
Animal caps were dissected at stage 9 and dissociated in CMFM
(Ca2þand Mg2þ free medium) and then treated with activin protein
(1 U/ml in 1 CMFM) for 1 h. The dissociated cells were subse-
quently plated in 1/2 MMR solution in the absence or presence of
25 μΜ CI3 into ﬁbronectin-coated chambered coverslips. Coverslips
were coated with 0.1 mg/ml ﬁbronectin (Sigma, diluted to the
appropriate concentration with PBS) for 2 h at room temperature.
For the migration assay, cells were analysed in the following
manner: a ﬁeld of cells was randomly chosen, and images were
captured at 5 min intervals for at least 100 min. The velocity of
single cells was measures with AxioVision Software 4.8.2.
Imaging analysis
Bright ﬁeld images were captured on a Zeiss LumarV12 ﬂuorescent
stereomicroscope. Fluorescent images were captured either under a
Zeiss Axio Imager Z1 microscope, using a Zeiss Axiocam MR3 and the
Axiovision software 4.8.2 or under a confocal LSM710 microscope
(Zeiss, Germany). Fluorescent intensity proﬁles were prepared using
ImageJ (National Institutes of Health, Bethesda, MD).
Results
Temporal and spatial expression of Xenopus Calpain2
To begin addressing the role of Calpain2 during Xenopus
development, we ﬁrst examined its temporal expression by
reverse transcriptase PCR (RT-PCR). Calpain2 mRNA was detected
in pre-gastrula stages and it continued to be expressed throughout
development (Fig. 1A). We also examined protein activity using
casein zymography, a method originally developed by Raser et al.
(1995). Brieﬂy, whole-embryo lysates from different developmen-
tal stages were run under non-denaturing conditions in a poly-
acrilamide gel that contained casein (a well known substrate of
Calpains). After electrophoresis, the gel was incubated overnight in
a buffer containing Ca2þ to activate Calpains. Calpain proteolytic
activity could then be visualised as clear bands against a blue
background after Coomassie Blue staining. As previously reported,
this technique allowed us to distinguish Calpain2 (left gel, lower
band, Fig. 1B) from Calpain1 (left gel, upper band, Fig. 1B) due to
their different mobilities in the gel. The sensitivity of the method
was tested by loading different amounts of the same sample and
checking for the proportional increase in the brightness of the
clearing band (middle gel, Fig. 1B). As expected, the activity of both
Calpains was inhibited by adding EDTA to the reaction buffer (right
gel, Fig. 1B). Although casein zymography is an activity assay, it
does not exactly reﬂect Calpain activation in vivo since calcium is
added in the reaction buffer, but it correlates well with the protein
Fig. 2. Inhibition of Calpains by CI3 causes severe delays in blastopore and neural tube closures. (A) Vegetal view of a stage 12 control embryo (left) and an embryo treated
with 100 mM CI3 from pre-gastrula stages (right). CI3-treatment severely delays blastopore closure. (B) Dorsal view of stage 18 control embryos (left) and embryos treated
with 100 mM CI3 from stage 11 (right). The addition of the inhibitor at this stage causes a signiﬁcant delay in neural tube closure. (C) Tailbuds of embryos treated with CI3 at
different times of development and rescued by removal of the inhibitor. Embryos in which the inhibitor was added at pre-gastrula stages and kept for the whole course of
development display a severe phenotype, with shorter and bent AP axes and loss of anterior structure (second image from the left). Embryos in which the inhibitor was
removed at stage 12 and replaced with fresh 0.1 MMR display a range of overall less severe phenotype, with normal heads but shorter and bent AP axes and some spina
biﬁda phenotypes (third image from the left). Embryos treated with CI3 from stage 11 onwards appear shorter, with reduced eyes and overall pigmentation (image to the
right). (D–F) Scoring of the phenotypes of embryos treated with the inhibitor from gastrula stages onwards (n¼73), inhibitor removed at stage 10.5 (n¼44), inhibitor
removed at stage 12 (n¼55) and treated from stage 11 (n¼46). Graphs indicate the per cent of embryos that display the phenotypes as depicted in the images above each
graph. Percentages are calculated on surviving embryos only. (D) Delays in blastopore closure are assessed in embryos at stage 12. Controls: blastopore¼0.2–0.25 mm, Mild
phenotype: blastopore¼0.35–0.5 mm. Severe phenotype: blastopore¼0.5–0.8 mm. (E) Delays in neural tube closure are scored in embryos at stage 18. (F) The range of
phenotypes observed at tailbud stages are classiﬁed in mild (normal head structure, shorter AP axis), severe (short and deformed embryos, completely lacking head
structures) and spina biﬁda. (G) Death rates of embryos treated with CI3 from gastrula stages onwards, inhibitor removed at stage 10.5 and at stage 12.
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levels (Raser et al., 1995). Using this technique, we concluded that
both Calpain1 and Calpain2 are maternal proteins expressed
throughout development.
We then examined the spatial distribution of Calpain2 by
whole-mount in situ hybridisation (WISH). In cleavage stage
embryos, Calpain2 mRNA accumulated primarily in the animal
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hemisphere (Fig. 1D) and the same localisation was maintained
during mid-blastula (Fig. 1E).
At gastrula stages, the Calpain2 transcript was detected in both
the ectoderm and mesoderm (Fig. 1F). As neurulation proceeds,
higher expression could be seen in the neural plate (Fig. 1G). At
stage 22, there was strong expression in the neural plate, in the
brain and in the eye (Fig. 1H). At tailbud stages, Calpain2 was also
expressed in the brain, neural crest cells, otic vesicle, branchial
arches, somites and eyes (Fig. 1I and J). Cross-section of a WISH-
stained tailbud embryo imaged under ﬂuorescence microscopy
showed clear expression in the neural tube and somites and weak
staining in the notochord (Fig. 1K). In the absence of commercially
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available antibodies able to discern the different Calpain isoforms,
immunoﬂuorescence analysis was performed on sections of
embryos injected with an HA-tagged Calpain2 mRNA to study its
subcellular localisation (Fig. 1C). In the dorsal mesoderm of a stage
12 embryo, HA-Calpain2 was strongly localised at the plasma
membrane and presumptive Golgi–ER complex, while a weaker
signal was detected in the cytoplasm (Fig. 1C, panel I), in agree-
ment with the previously reported localisation of Calpain2 in cell
lines (Hood et al., 2004; Shao et al., 2006). In the prospective
neurectoderm at early gastrula stage, HA-Calpain2 distribution
appeared diffuse in the cytoplasm with only a weak signal at the
membrane (Fig. 1C, panel II). At neurula stage, Calpain2 was
strongly localised at the plasma membrane in neural ectodermal
cells (Fig. 1C, panel III). These differences in cellular localisations
may reﬂect different states of activation of Calpain2, as previously
observed in cell lines (Wells et al., 2005). The changes in Calpain2
localisation temporally coincide with the periods of active mor-
phogenetic movements in the mesoderm and neurectoderm
respectively, suggesting a possible involvement of Calpain2 in
morphogenesis.
Calpain inhibition delays both blastopore and neural tube closures
In order to investigate the speciﬁc role of Calpains during
Xenopus development, we carried out experiments in which we
treated embryos with a reversible calpain inhibitor (Calpain
inhibitor III, CI3) for different lengths of time during development.
Although the blastopore lip formed normally, 76% of embryos
treated at pre-gastrula stages with 100 mM of inhibitor showed
delays in blastopore closure (Fig. 2A and D), and 40% initiated
neurulation when the blastopore was still open (Fig. 2E). Most of
the embryos treated with CI3 died during gastrulation and
neurulation and only 30% reached tailbud stages (Fig. 2G) and
displayed severe deformities with very short and dorsally bent
axes and complete loss of anterior structures (Fig. 2C and F). The
fact that CI3 is a reversible inhibitor, allowed us to pinpoint the
major developmental stages in which Calpain activity is required
by removing the inhibitor at different times. Removal of the
inhibitor at stage 8 (pre-gastrula) resulted in embryos which were
completely normal (data not shown), suggesting that Calpain
activity is not required during blastula stages. Removal of the
inhibitor at gastrula stages (stages 10.5 and 12) signiﬁcantly
increased the overall survival of the embryos to levels comparable
to those observed in controls (Fig. 2G) and led to 71% and 48% of
complete phenotype rescue at tailbud stage, when the inhibitor
was removed at stage 10.5 and 12, respectively (Fig. 2F). The rest of
the embryos displayed several gastrulation defects, including
marked shortening of the AP axis and spina biﬁda that resulted
from abnormal blastopore closure (Fig. 2C and F). These results
suggested that Calpains play a crucial role during gastrulation.
Furthermore, embryos treated with the inhibitor at stage 11
onwards gastrulated normally (Fig. 2D), but neural tube closure
was markedly delayed (Fig. 2B and E), leading to shorter tailbuds
with smaller eyes, kinked tails and reduced pigmentation (Fig. 2C).
Given the impossibility to determine the time the inhibitor takes
to permeate the embryo and to rule out possible non speciﬁc
toxicity during early development, we generated a dominant-
negative form of Xenopus Calpain2 by mutating the active site
Cystein 105 into Serine (Capn2C105S). This mutation is reported to
inactivate the enzyme, without affecting its overall structure or
binding capacity (Arthur et al., 1995; Huang and Forsberg, 1998;
Masumoto et al., 1998) and a Calpain8 protein mutated at this
amino acid position has been previously used as a dominant
negative in Xenopus embryos (Cao et al., 2001). Injection of 1 ng
Capn2C105S at the 2-cell stage caused a signiﬁcant delay in
blastopore closure (Suppl. Fig. 1A), as previously observed in
embryos treated with CI3. At tailbud stage, Capn2C105S-injected
embryos appeared severely deformed, shorter, dorsally bent and
some displayed spina biﬁda (Suppl. Fig. 1B), again resembling CI3-
treated embryos.
Overall, these experiments suggested a crucial role for Calpains
during gastrulation and neurulation. However, although CI3 is one
of the most speciﬁc calpain inhibitors currently available, it is still
reported to inhibit both Calpain1 and 2 due to their high sequence
identity. For the same reason, we cannot exclude that Capn2C105S
may also block other highly homologous Calpain isoforms. Given
the fact that disruption of Calpain2 gene in mice led to embryonic
lethality (Dutt et al., 2006; Takano et al., 2011), whereas knockout
for Calpain1 resulted in fertile adult mice with reduced platelet
aggregation (Azam et al., 2001), we decided to selectively block
Calpain2 by morpholino antisense oligonucleotide (MO). Embryos
were injected with 50–70 ng (total) of Calpain2 MO either at 1-cell
stage or 2 out of 2 blastomeres at 2-cell stage and monitored
during development. Western blotting analysis of 50 ng MO-
injected embryos showed undetectable protein levels of mRNA-
injected HA-tagged Calpain2 at stage 13 (Fig. 3J). In the absence of
an available Xenopus Calpain2 speciﬁc antibody to analyse endo-
genous Calpain2 downregulation as a result of MO injection, we
used casein zymography analysis. This revealed that only a slight
reduction in endogenous Calpain2 levels was observed at stage 13
following the injection of 50 ng MO (not shown), but a 40% was
observed later at stage 19 (Fig. 3K). A 50% downregulation of
activity at stage 13 was achieved by increasing the amount of
injected MO to 70 ng (Fig. 3K). The discrepancy observed in the
amount of downregulation between HA-Capn2 and endogenous
Calpain2 is probably due to the presence of stable maternal
protein, since examination of the EST database did not reveal the
presence of any pseudoalleles.
Fig. 3. Calpain2 downregulation by morpholino antisense oligonucleotide (MO) leads to mild delays in blastopore closure and severe defects during neural morphogenesis.
(A) Vegetal view of stage 12.5 control embryos (bottom) and embryos injected with 70 ng MO at 1-cell stage (top). MO-injected embryos show mild delays in blastopore
closure (blastopore of controls embryos¼0.2–0.25 mm; blastopore of MO-injected embryos¼0.35–0.5 mm). (B) Dorsal view of a stage 18 control embryo (top) and an
embryo injected with 70 ng MO at 1-cell stage (bottom). The MO-injected embryo show marked delays in neural tube closure. (C) Dorsal and anterior views of stage 20
embryos injected with the MO as in B. At this stage, dorsal neural folds appear to be fused in the MO-injected embryos (top, third embryo to the right) as in controls (bottom,
embryo in the middle). However, anterior neural tube is still open in MO-injected embryos (top, ﬁrst and second embryos from the left) whereas it is completely closed in
controls (bottom, ﬁrst and third embryos). (D–F) Tailbuds of control embryos (D), embryos injected with 70 ng MO at 1-cell stage (E) and embryos in which the same amount
of MO was co-injected with 500 pg Capn2R (F). MO injections cause shortening of the AP axis and head malformations (E) and this phenotype is successfully rescued by
Capn2R(F). (G) Delays in blastopore closure and during neurulation are scored in embryos (injected as in A) at stage 12 and 18, respectively (n¼71). Graphs indicate the
percentage of embryos that display the phenotypes as depicted in the images above each graph. (H) Tailbuds of embryos injected with the MO as in A are scored for their
phenotypes. They were classiﬁed in short (shorter AP axes), short and bent (shorter and dorsally curved AP axes) and severe (short and deformed embryos, completely
lacking head structures). Graphs indicate the percentage of embryos that display the phenotypes as depicted in the images above each graph (n¼46). (I) Dorsal view of the
head of a tailbud injected with 15 ng MO at 1 out of 2 blastomeres. Loss of the eye structures (arrow) and reduced pigmentation are observed in the injected side (indicated
by an asterisk). (J) Western blot analysis detecting HA-tagged Capn2 in lysates of stage 13 embryos. mRNA (200 pg) encoding HA-Capn2 is co-injected with or without MO
(50 ng). This amount of MO completely blocks the translation of HA-Capn2. (K) Casein zymography analysis showing endogenous Calpain1 (top) and Calpain2 (bottom)
activities in lysates of MO-injected embryos. Injection of 50 ng MO causes a 40% reduction in Calpain2 expression at stage 19 (arrow). Injection of 70 ng MO causes a 50%
reduction in Calpain2 expression at stage 13 (arrowhead). Densitometry analysis was performed using ImageJ software and the samples were corrected for loading in
correlation with Capn1.
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80% of embryos injected with 70 ng MO showed a slight delay
in blastopore closure during gastrulation (Fig. 3A and G), but in all
cases the blastopore eventually closed. This phenotype is clearly
milder than the one observed in CI3-treated embryos. This is not
surprising since we showed a relatively late downregulation of
Calpain2 by MO (Fig. 3K), whereas the inhibitor efﬁciently blocked
protein activity from early stages. During neurulation, all MO-
injected embryos presented a similar phenotype to embryos
treated with CI3 from stage 11, showing a marked delay in neural
tube closure (Fig. 3B and G). Particularly, anterior neural tube
closure was more severely affected than the posterior neural tube
which eventually closed (Fig. 3C). At tailbud stage, MO-injected
embryos displayed a range of developmental abnormalities
(Fig. 3E) that were scored based on their severity (Fig. 3H). 24%
of the embryos displayed a very severe phenotype, with much
shorter AP axis and complete loss of head structures. 39% showed
a short and dorsally bent body axis and eye reduction, whereas
33% had a short axis and eye reduction (Fig. 3H). Overall, the
phenotypes of the MO-injected embryos resembled those
observed in CI3-treated and Capn2C105S expressing embryos
(Fig. 3E and H compared with Fig. 2C and F and Suppl. Fig. 1),
with the exception of the spina biﬁda phenotype that was not
observed in MO-injected embryos. Injections of lower amounts
(15 ng) of MO at 1 out of 2 blastomeres led to an overall milder
phenotype with loss of eye structures and decreased overall
pigmentation (Fig. 3I).This may result from impaired migration
of neural crest cells, as previously shown for downregulation of
the highly homologous Calpain8 (Cousin et al., 2011). However,
this has not been investigated further in the present study.
The overall phenotype caused by 70 ng MO injections was fully
rescued by co-injecting 500 pg mRNA of HA-Capn2R (lacking the
5′UTR region recognised by the MO) demonstrating the speciﬁcity
of the MO (Fig. 3F). Injection of 70 ng control MO did not elicit any
abnormal phenotype (not shown) providing further evidence that
the phenotype observed in the morphants was speciﬁc.
Calpain inhibitor blocks mesoderm convergent extension and affects
mesoderm migration
To exclude the possibility that the gastrulation defects we
observed in embryos treated with the Calpain inhibitor are due
to defects in mesoderm induction, we performed whole mount
in situ hybridisation for the pan-mesodermal marker Brachyury
(Xbra). The intensity of Xbra staining at stage 11 was similar
between treated and untreated embryos (Fig. 4A), suggesting that
CI3 does not affect mesoderm induction. At stage 12, in control
embryos Xbra staining revealed a tight ring around the yolk plug
and a long, narrow notochord. In contrast, in treated embryos Xbra
Fig. 4. Calpain inhibition by CI3 completely blocks mesoderm convergent extension and affects mesoderm migration without altering cell fate. (A–C) WISH showing the
expressions of mesodermal markers Xbra (A and B) and Chrd (C) in embryos treated with CI3 from 2-cell stage onwards. Inhibition of Calpains does not affect the expression
and localisation of Xbra and Chrd at early gastrula stages (A and C). (B) Sagittal sections of Xbra-stained embryos at stage 12 showed a shorter notochord in CI3-treated
embryos compared to controls. (D) A 50 mM CI3 inhibitor completely blocks the activin-induced elongation of animal caps explants in 3 independent experiments.
(E) Migration rates of CI3-treated or untreated mesodermal cells derived from activin-treated dissociated caps (values shown are means7s.e.m., n¼25). Abbreviations: A,
anterior: P, posterior.
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Fig. 5. Downregulation of Calpain2 by MO affects cell movements during neural tube closure. (A) Frames from a 175 min time-lapse movie of an embryo injected at 1 out of
two blastomeres with 30 ng MO (left embryo in each frame) and an embryo in which the same amount of MO was co-injected with 300 pg Capn2R mRNA (right embryo in
each frame). White dashed lines outline the width of the neural plate. Time (t) in minutes is shown at the top right of each frame. The injected side of the embryo is shown by
FITC ﬂuorescence in the top left inset in the ﬁrst frame. The severe delay in neural plate movement caused by MO injection is successfully rescued by Capn2R. (B) Targeted
injection of 20 ng MO at 1 dorsal blastomere at 4-cell stage is sufﬁcient to cause the severe delay in neural plate movement. The injected side is visualised by FITC
ﬂuorescence (inset) and indicated by an asterisk. White lines show the width of the neural plate. (C) WISH for neural marker Sox2 in a stage 16 embryo co-injected with
20 ng MO and 50 pg mGFP at 1 dorsal blastomere at 4-cell stage. The injected side is determined as described in F and it is marked by an asterisk. Sox2 expression is wider in
the MO-injected side. (D) WISH for the neural fold marker Pax3 in a stage 18 embryo injected as in C. The injected side is marked by an asterisk. Pax3 expression is shifted
laterally in the MO-injected side. (E) RT-PCR analysis shows that Sox2 expression is not affected by MO-injection in XBF2-induced animal caps. Sox2 expression levels have
been calculated using ImageJ and normalised against the loading control. (F) High magniﬁcation of the neural plate of a Sox2-stained embryo injected as in C and
subsequently stained with an anti-GFP antibody and visualised by ﬂuorescent microscopy. mGFP staining (green) identiﬁes the injected side (asterisk). Sox2 staining is
shown in red. The width of Sox2 staining is measured using ImageJ software. (G) Quantiﬁcation of the width of Sox2 expression. The width was measured as described in F. As
shown by the graph, the width of Sox2 expression is signiﬁcantly wider in the MO-injected sides than in the uninjected ones. Co-injection with 250 pg Capn2R clearly
rescues the phenotype (values shown are means7s.e.m., n¼15). (H) Tailbud of an embryo injected with MO as in B. It presents a lateral bending towards the MO-injected
side (indicated by an asterisk), probably due to decreased elongation of this side of the embryo. (I) WISH for the neural fold marker Pax3 in a stage 28 embryo injected with
40 ng MO at both dorsal blastomeres at 4-cell stage. Injection of the MO disrupts anterior neural tube closure (arrow).
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formed a larger ring around the yolk plug in agreement with an
impairment of blastopore closure and stained a short and broad
notochord (Fig. 4B, insets top left). Sagittal sections of Xbra-stained
embryos conﬁrmed that in CI3-treated embryos the chordal
mesoderm failed to elongate suggesting inhibition of convergent
extension and/or mesoderm migration (Fig. 4B). In situ hybridisa-
tion for Chordin (Chrd), a dorsal marker expressed in the gastrula
organiser and in the notochord at later stages, showed no
difference in its expression level and localisation at stage 10.5 in
CI3-treated and untreated embryos (Fig. 4C), indicating that
dorsoventral patterning was not affected. We concluded that
blocking Calpain activity did not affect the levels of expression of
mesodermal markers but altered their localisation, suggesting that
the gastrulation defects observed in CI3-treated embryos are not
due to defective mesodermal speciﬁcation, but probably to per-
turbed movements of mesodermal cells. Furthermore, we exam-
ined the effect of Calpain inhibition on conventional Wnt
signalling, since Calpains have been previously reported to cleave
β-catenin in vitro (Benetti et al., 2005; Rios-Doria et al., 2004). RT-
PCR analysis of Xnr3, a direct target of the canonical Wnt pathway
(Smith et al., 1995), showed that CI3 treatment did not appreciably
affect Xnr3 expression (Suppl. Fig. 1C). This suggests that Calpains
do not modulate β-catenin transcriptional targets, at least at this
early stage of development.
Blastopore closure is a complex process and several morpho-
genetic movements can inﬂuence it including convergent exten-
sion and mesoderm migration (Stylianou and Skourides, 2009;
Wallingford et al., 2002). During gastrulation, the head mesoderm
that involutes at the blastopore lip adheres to the ﬁbronectin
matrix of the blastocoel roof and actively migrates towards the
animal pole of the embryo, a movement known as mesoderm
migration. As they involute, mesodermal cells also converge along
the mediolateral axis and extend along the anteroposterior axis
(Keller et al., 2008; Wallingford et al., 2002). In an effort to better
understand the underlying mechanism responsible for the phe-
notype induced by Calpain2 inhibition, we began by examining the
role of Calpain2 on convergent extension using the well estab-
lished animal cap elongation assay. Animal caps were dissected
from CI3-treated and control embryos at stage 8 and subsequently
induced with activin. While control explants elongated normally,
those excised from CI3 treated embryos (50–100 mM CI3)
remained almost completely round (Fig. 4D) indicating that con-
vergent extension was severely impaired. Knockdown of Calpain2
by MO-injection blocked animal cap elongation, although not
completely as in CI3-treated caps (Suppl. Fig. 1D), This is most
likely because the MO does not completely downregulate Calpain2
at gastrula stages as we have shown above (Fig. 3K) and this is in
agreement with the relatively mild phenotype observed during
gastrulation in MO-injected embryos (Fig. 3A).
To assess whether Calpain activity is also required for mesoderm
migration, we analysed cell movements of dissociated activin-
treated caps, plated on ﬁbronectin-coated cover slips. Mesodermal
cells adhered, spread and began migrating normally in the presence
of the inhibitor. However time-lapse recordings showed that CI3-
treated cells moved signiﬁcantly slower than controls (Suppl. Movie
1). Indicative cell traces of controls and CI3 treated cells are shown
in Suppl. Fig. 1E. Migration rates were calculated and showed an
overall 45% reduction for treated cells compared to controls
(Fig. 4E). Calpain activity is thus not strictly required for mesoderm
migration but it modulates migration rates.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2013.09.017.
Overall, these data show that Calpain inhibition by CI3
completely blocks mesoderm convergent extension and modu-
lates mesoderm migration. This suggests that both defects are
likely responsible for the failure of blastopore closure, although
impairment of convergent extension seems to be the major
determinant.
Calpain2 downregulation affects neural tube closure without
interfering with neural induction or patterning
As discussed above, both CI3 treatment as well as Calpain MO
injections resulted in defects of neural tube closure. Time-lapse
recordings of MO-injected embryos (1 out of 2 blastomeres)
revealed a marked delay in neural tube closure, with the anterior
neural plate remaining open at stage 18 (Suppl. Movie 2). The
phenotype could be successfully rescued by co-injecting Capn2R
mRNA with the MO, as shown by a normal movement of the
neural ectoderm towards the midline, as in controls (Fig. 5A and
Suppl. Movie 3). MO injection in one dorsal blastomere at the
4-cell stage to target the neural plate was sufﬁcient to cause the
same severe delay in neural tube closure (Fig. 5B), suggesting that
Calpain2 function is required for the shaping of the neural plate.
Tailbuds from these embryos displayed pronounced lateral bend-
ing towards the MO-injected side, suggesting that this side did not
elongate as much as the uninjected side (Fig. 5H). Furthermore, we
examined the expression and localisation of the pan-neural
marker Sox2 by RT-PCR and in situ hybridisation. While the
expression level of this marker was unaffected in MO-injected
embryos (Fig. 5E), its localisation denoted a wider neural-plate
region in the MO-injected side (Fig. 5C). Quantiﬁcation of the
width of Sox2 expression conﬁrmed that the neural plate in MO-
injected sides was signiﬁcantly wider than in the uninjected sides
(Fig. 5F and G). Co-injection of Capn2R mRNA with MO decreased
the width of the Sox2 expression domain (Fig. 5G), conﬁrming
once again the speciﬁcity of the MO. In situ hybridisation for the
lateral neural plate marker Pax3 at stage 18 showed that its
expression was shifted laterally in the injected side (Fig. 5D), again
indicating a delay in neural tube closure. In some MO-injected
embryos with more severe phenotypes, Pax3 expression at tailbud
stages revealed neural folds that failed to fuse (Fig. 5I). Similar
expression patterns for Sox2 and Pax3 at neurula and tailbud
stages were observed in embryos treated with CI3 from stage 11
(data not shown). Overall, these data suggested that the delay in
neural tube closure observed in embryos in which Calpain2
activity had been downregulated may, at least in part, result from
defects in neural convergent extension.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2013.09.017.
Calpain2 downregulation blocks neural convergent extension
During neurulation, the cells of the neural ectoderm intercalate
along the mediolateral axis generating a longer and thinner tissue.
Defects in neural convergent extension result in shorter embryos
with a wider neural plate and an open neural tube (Wallingford
et al., 2002), similar to those we described above. We set to
determine if Calpain2 is indeed necessary for neural convergent
extension by using XBF2-injected ectodermal explants (animal
caps). XBF2 expression induces neural fate without inducing
mesoderm. These explants undergo convergent extension leading
to different degrees of elongation (Mariani and Harland, 1998;
Wallingford and Harland, 2001). As expected, 50% of XBF2-injected
controls showed a mild elongation and 40% strong elongation
(Fig. 6A and D). Co-injection of MO signiﬁcantly inhibited explant
elongation (Fig. 6B), with 50% of the caps showing no elongation at
all (Fig. 6D). In explants treated with 50 mM CI3, convergent
extension was completely blocked and the caps remained com-
pletely round (Fig. 6C and D). We also examined convergent
extension in neural plate explants that contained the underlying
mesoderm, as previously described (Elul and Keller, 2000;
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Borchers et al., 2006). Calpain2 MO also signiﬁcantly inhibited the
elongation of these explants that better reﬂect the in vivo situation
(Fig. 6E and F). Images of the elongating explants were taken every
2 h and the change in length was measured. While control
explants exponentially elongate over time, MO-injected explants
initially elongated but began to gradually reach a plateau after 2 h
(Fig. 6E). Additionally, MO-injected explants remained wider than
controls (Fig. 6F). In conclusion, these results show that Calpain2
downregulation inhibits convergent extension movements in both
neuralised ectodermal explants and in neural plate explants,
conﬁrming that at least in part the observed neural tube closure
defects in both morphants and CI3 treated embryos stem from
defects in convergent extension movements.
Inhibition of Calpains affects correct cell polarisation required for
convergent extension movements
Since Calpain inhibition abolishes convergent extension move-
ments in both mesodermal and neural tissues without affecting
mesoderm or neural speciﬁcation, we wanted to further probe the
mechanism behind this effect. One possibility is that Calpain2
activity is required for adherens junction turnover and remodel-
ling, which is in turn required for cell intercalation. Adherens
junction molecules have been identiﬁed as Calpain targets in
different cell lines (Benetti et al., 2005; Jang et al., 2009; Rios-
Doria et al., 2003) and it is also known that both overexpr-
ession and loss of cadherins interferes with convergent extension
Fig. 6. Downregulation of Calpain2 expression by MO inhibits neural convergent extension. (A–C) Neural convergent extension was analysed in XBF2-injected animal caps.
One-cell stage embryos were injected with 100 pg XBF2 either alone (A) or co-injected with 70 ng MO (B) or treated with 50 mM CI3 (C). The inset in B shows MO localisation
in the explants as shown by FITC ﬂuorescence. (D) Percentage of elongated explants from the experiment described in A–C. Explants with different degrees of elongation
were grouped according to their length to width ratio (LWR). Black indicates a strong elongation (LWR42), grey a mild elongation (LWR¼1.2–2) and white no elongation
(LWR¼1–1.2). (XBF-2 injected, n¼26; MO, n¼23; CI3, n¼24). (E–F) Neural convergent extension was analysed in neural plate explants. (F) Neural plate explants excised
from stage 12–12.5 control (top panel) or MO-injected (bottom panel) embryos were left to elongate. The time (in hours) at which each picture was taken is indicated above.
The inset of the last image in the bottom panel shows FITC ﬂuorescence. (E) The graph shows the change in length (Δlength) over time in control (red) and MO-injected
(green) neural explants that were prepared as in (F). The lengths were measured using ImageJ software. The plotted data are means7s.e.m (n¼10). Abbreviations: LWR,
length to width ratio.
S. Zanardelli et al. / Developmental Biology 384 (2013) 83–100 93
Fig. 7. Inhibition of Calpains affects the morphology and motility of mesodermal cells. Still frames from time-lapse movies of control (A) and CI3-treated (B) DMZ explants.
mGFP was used as a lineage tracer. Time (t) in minutes is shown at the top left of each frame. Outlines of randomly chosen cells (1, 2, 3 in control explants and 1′, 2′, 3′ in CI3-
treated explants) are shown to the right of each panel. They were drawn from the ﬁrst (pink) and last (grey) frames of the movie and superimposed. Black arrows indicate the
direction of migration for each cell. The black double arrow head represents the orientation of the antero-posterior (AP) axis. Cells in CI3-treated explant show alteration in
morphology, orientation and motility. (C) Outlines of cells from an intermediate frame were traced and their long axes indicated with red arrows. The black double arrow
head represents the orientation of the AP axis. In control explants, the cells are polarised along the medio-lateral axis. In CI3-treated explants, some cells show identical
polarisation axis but the overall tissue polarity is disrupted. (D) Circular diagram of LWR versus the angle of the long axis of each of cells in A and B. Controls cells are
clustered mediolaterally. Cells in CI3 treated explants are distributed randomly. Circular diagram prepared using Oriana 4.01 software.
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movements (Niessen et al., 2011). To explore this possibility we
decided to examine the effects of Calpain2 inhibition on meso-
derm radial intercalation, another intercalative activity that
requires adherens junction remodelling and turnover. Open-
faced Keller explants were excised at stage 10.5 and placed on
ﬁbronectin-coated coverslips. The tissue architecture of the
mesendodermal sheet in such explants mimics the architecture
of the mesendodermal mantle in whole embryos. These explants
initially contain multiple layers of cells but when placed on
ﬁbronectin they thin into a monolayer via radial intercalation as
the mesendoderm migrates out from the axial mesoderm
(Davidson et al., 2002). Remarkably radial intercalation was
unaffected in the presence of the CI3 inhibitor (Suppl. Fig. 2), with
the mesendoderm thinning into a monolayer suggesting that
adherens junction turnover is not signiﬁcantly affected under
these conditions. It is thus unlikely that the mechanism through
which Calpain inhibition blocks convergent extension movements
is via inhibition of adherens junction remodelling.
Another possible mechanism through which Calpain2 could
affect convergent extension is via modulation of the PCP pathway.
It is known that during convergent extension, cells acquire an
elongated bipolar shape and form protrusions predominantly
oriented along their long axis. This polarised morphology pro-
motes mediolateral cell intercalation that ultimately leads to
narrowing of the mediolateral axis (convergence) and elongation
of the anteroposterior axis (extension) (Keller et al., 2003). To
investigate whether inhibition of Calpain activity inﬂuences the
polarised behaviour and motility of these cells, we analysed cell
shape and motility in mGFP-injected DMZ explants in the absence
and presence of CI3. The explants were dissected at stage 10.5 and
time-lapse recordings were generated over 10 min (Suppl. Movies
4 and 5). While in control explants movements appeared direc-
tional and coordinated (Suppl. Movie 4 and Fig. 7A), in CI3-treated
explants cell movements were impaired and the protrusive activ-
ities of the cells appeared randomised (Suppl. Movie 5 and Fig. 7B).
Examining still frames from these time-lapse sequences, we could
analyse the morphology and orientation of individual cells. As
shown in Fig. 7C, the majority of the cells in control explants
showed the typical elongation and were oriented perpendicular to
the anterior–posterior axis. In CI3-treated explants, however, the
overall tissue polarity was disrupted and some cells also failed to
acquire the typical bipolar shape and remained more round
(Fig. 7C). These observations were conﬁrmed by plotting the
length to width ratio (LWR) of each cell against the angle of its
long axis (Fig. 7D). The circular diagram clearly shows that control
cells are mediolaterally polarised, whereas cells in CI3-treated
explants are randomly oriented (Fig. 7D). Furthermore, 52% of CI3-
treated cells did not signiﬁcantly elongated (LWRo2), whereas in
controls only 19% of the cells remained round. Overall, these data
suggest that downregulation of Calpain2 activity does not lead to a
signiﬁcant defect of adherens junction turnover and that conver-
gent extension defects are likely due to loss of proper cell polarity
required for this movement.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2013.09.017.
Expression of Wnt5a induces the translocation of Calpain2 to the
membrane
It is known from in vitro studies and crystallography data that
Calpains display a strict Ca2þ requirement for their activity. In the
absence of Ca2þ , Calpains are predominantly found in the cyto-
plasm in an inactive form. In the presence of Ca2þ , Calpains
translocate to the plasma membrane and become activated
(Suzuki et al., 2004). This was conﬁrmed by treating stage
9 embryos with the calcium inophore Ionomycin, which lead to
a dramatic relocalization of Calpain2 from the cytosol to the
plasma membrane (Suppl. Fig. 3). The existence of a calcium-
mediated pathway that is activated by speciﬁc Wnt proteins
(Wnt4, Wnt5a, Wnt11) has been described in Xenopus and it is
known to be important for the regulation of convergent extension
through the activation of several calcium-dependent proteins
(Kuhl et al., 2000a, 2000b; Sheldahl et al., 1999). This raised the
possibility that loss of polarity and block of convergent extension
movements is due to Calpain2 involvement in this pathway. We
therefore initially set to investigate if Calpain2 is activated down-
stream of the Wnt/Ca2þ signalling pathway via expression of
Wnt5a. HA-Calpain2 mRNAwas microinjected in Xenopus embryos
either alone or with Wnt5a, animal caps were excised at stage
9 and stained with an anti-HA antibody. Cell-boundaries were
visualised with a C-cadherin antibody. HA-Calpain2 was present
throughout the cytoplasm in the absence of exogenous Wnt
signalling. Following co-injection of Wnt5a, HA-Calpain2 translo-
cated to the plasma membrane (Fig. 8A). Fluorescence-intensity
proﬁles for HA-Calpain2 and C-cadherin were generated, showing
that C-cadherin and Calpain2 clearly co-localised at membrane
regions in response to Wnt5a expression (Fig. 8B).
It has been previously shown that the multifunctional protein
Dishevelled (Dsh), known to be a key activator of both canonical
Wnt and PCP pathways, also functions in the Wnt/Ca2þ by
activating intracellular calcium ﬂux and promoting the transloca-
tion to the membrane of two Ca2þ-sensitive enzymes, PKC and
CamKII (Sheldahl et al., 2003). We therefore set to determine if
Calpain2 localisation to the membrane is mediated by Dsh, by
using a well characterised dominant negative mutant of Dsh, Xdd1
(Sokol, 1996). Calpain2 localisation to the membrane in neural
ectodermal cells of a stage 13 embryo was clearly reduced in
Xdd1-injected embryos (Fig. 8C), suggesting that Dsh is important
for Calpain2 membrane localisation. To further address the role of
Calpain2 as an effector of the Wnt/Ca2þ pathway, we assessed
convergent extension in activin-induced caps from control
embryos and embryos injected with Wnt5a alone or co-injected
with Calpain2 dominant negative (Capn2C105S). In agreement
with previously published data, injection of Wnt5a inhibited the
elongation of these explants, conﬁrming the role of the Wnt/Ca2þ
signalling pathway in regulating convergent extension (Moon
et al., 1993; Torres et al., 1996; Yamanaka et al., 2002). Remarkably,
co-expression of Capn2C105S clearly reversed the inhibitory effect
of Wnt5a on cap elongation (Fig. 8D), suggesting that Wnt5a
blocks convergent extension in part through excessive activation
of endogenous Calpain2. A precise regulation of Calpain2 activity is
thus necessary, since both overactivation and inhibition of Cal-
pain2 activity lead to impairment of convergent extension move-
ments, as previously reported for other effectors of the Wnt
pathways (Borchers et al., 2006; Djiane et al., 2000; Wallingford
and Harland, 2001; Wallingford et al., 2000).
Overall our results identify Calpain2 as a new calcium-sensitive
enzyme that via activation through the Wnt/Ca2þ pathway
through Dsh can modulate convergent extension movements.
Discussion
In the present study, we investigated the role of the calcium
protease Calpain2 during X. laevis development. We initially
analysed Calpain2 temporal expression at both the mRNA and
protein levels by RT-PCR and casein zymography, respectively.
Both methods revealed that Calpain2 is a maternal protein
expressed throughout development. We also examined its spatial
distribution by in situ hybridisation. In pre-gastrula and gastrula
stages, Calpain2 localises asymmetrically along the animal–vegetal
axis, with a broad staining detected mainly at the animal pole.
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Fig. 8. Wnt5a elicits Calpain2 translocation to the plasma membrane. (A) Animal caps from embryos injected with 200 pg HA-Capn2 alone (top panels) or co-injected with
500 pg Wnt5a (bottom panels) are double stained for C-cadherin (green) and HA-Calpain2 (red). Plasma membrane can be visualised in both top and bottom panels by
C-cadherin staining. In the absence of Wnt5a (top panel) Calpain2 is mainly diffused in the cytoplasm, whereas in the presence of Wnt5a there is a clear increase in its
membrane localisation. Scale bar¼20 μM. (B) Co-localisation studies in individual groups of cells in the absence (top panel) or presence of Wnt5a (bottom panel).
Fluorescence-intensity proﬁles are shown to the right and represent the areas marked by the white line. Numbering represents membrane regions. Only in the presence of
Wnt5a C-cadherin and Calpain2 show clear co-localisation at membrane regions, as determined by ﬂuorescence-intensity overlap. Pixel intensity proﬁles were generated
using ImageJ software. Scale bar¼20 μM. (C) Ectodermal cells of stage 13 embryos injected with 200 pg HA-Capn2 alone or co-injected with 1 ng Xdd1 stained with anti-HA
antibody. Scale bar¼20 μM (D) Injection of 100 pg Wnt5a blocks the activin-induced elongation of animal caps explants. Co-injection of 1 ng Capn2 C105S reverses the
inhibition of elongation caused by Wnt5a.
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Similar asymmetrical distributions in early embryos have been
previously reported for some maternal mRNAs (Lee et al., 2009;
Rebagliati et al., 1985; Schroeder and Yost, 1996; Weeks and
Melton, 1987). During gastrulation, the protease is expressed
predominantly in the ectoderm and mesoderm. This is in agree-
ment with a previous analysis of distribution of Calpains in
Xenopus performed by immunohistochemistry (Moudilou et al.,
2010). As development proceeds, increased levels of Calpain2 are
detected in the neural tube, brain, neural crest, otic vesicle,
branchial arches, eyes and somites. A similar distribution of
Calpain2 was reported in E8.5–11.5 mouse embryos (Raynaud
et al., 2008). Overall, Calpain2 appears elevated in tissues that
undergo intense cell migration or morphogenesis.
We investigated Calpain2 speciﬁc function during embryogen-
esis using a reversible Calpain inhibitor, an active-site Calpain2
dominant negative and a morpholino antisense nucleotide
designed to speciﬁcally block Calpain2 translation. Using these
approaches, we provide evidence that Calpain2 function is essen-
tial during Xenopus gastrulation and neurulation, regulating both
mesoderm migration and convergent extension movements.
Embryos treated with the inhibitor at gastrula stages show
delayed mesoderm involution and ultimately fail to close the
blastopore, resulting in shorter embryos and spina biﬁda. Similar
results were obtained when Capn2C105S was used to block
endogenous Calpain2. We show that both mesoderm convergent
extension and mesoderm migration are impaired in CI3-treated
embryos, but the expression of mesodermal markers is unaffected.
At the moment we cannot exclude the possibility that the
observed phenotype may result from the concomitant inhibition
of Calpain1, since the inhibitor used could block both Calpain1 and
Calpain2 activities and also the Capn2C105S dominant negative
could potentially inhibit both Calpains given their high sequence
identity. Considering that disruption of Calpain2 gene in mice
resulted in early embryonic lethality (Dutt et al., 2006; Takano
et al., 2011), whereas knockout mice for Calpain1 presented only
mild defects in platelet aggregation (Azam et al., 2001), it is likely
that blockage of Calpain2 is the main factor in determining the
phenotype we observed. Furthermore, although the CI3 inhibitor
is reported to be speciﬁc for Calpains 1 and 2, we cannot exclude a
partial inhibition of Calpain8, a tissue-speciﬁc Calpain that shares
52% of amino acid sequence identity with Calpain2 and has also
been shown to be involved in convergent extension movements
(Cao et al., 2001). However, the spatial and temporal expressions
of Calpain8 described in the same study are not in agreement with
a role in convergent extension or neural tube closure. Calpain8
mRNA is ﬁrst detected at stage 10, localises at the ventral side of
the blastopore at gastrula stages and it is not detectable in the
neural plate at neurula stages (Cao et al., 2001).
In addition to the defects in mesodermal morphogenesis, all
three loss of function approaches also result in defects of neural
tube closure. This is a signiﬁcant ﬁnding given the fact that neural
tube defects are among the most common human birth defects but
their molecular basis has not yet been fully addressed
(Wallingford, 2005, 2006). Targeting the neural plate with the
Calpain2 MO allowed us to speciﬁcally downregulate Calpain2 in
neural tissues. The morphants show a marked delay in neural tube
closure, in agreement with the CI3 inhibitor treatment suggesting
that Calpain2 is necessary for this process. Since Calpain2-MO
inhibits neural convergent extension in both BF2-induced animal
caps and in neural explants it appears that, at least in part, the
delay in neural tube closure observed in Calpain2 morphants is
due to problems with convergent extension. However, we cannot
exclude that Calpain2 downregulation may affect other processes
that are known to be crucial for neural tube closure. Apical
constriction of the cells of the neural tube, for example, is
responsible for driving the elevation of the neural folds and
ciliogenesis has been shown to be important for rostral neural
tube closure (Wallingford, 2005). A possible involvement of
Calpain2 in the regulation of these processes will be studied in
the future.
We further investigated the possible molecular mechanism
behind Calpain2 requirement in convergent extension movements
of both neural and mesodermal tissues. Our experiments using
open-faced Keller explants suggest that loss of proper cell polarity,
rather than inhibition of adherens junction turn over, is likely the
cause of the defects in convergent extension we observe when
Calpain activity is downregulated.
It is known that in vitro, Calpain2 requires Ca2þ concentrations
(4500 mM) that are considerably higher than the physiological
intracellular concentrations of Ca2þ (usually o1 mM) (Goll et al.,
1992). This ensures a tight regulation on Calpain2 activation, being
achieved only after speciﬁc stimuli able to open calcium channels
or to activate calcium release from intracellular stores (Leloup
et al., 2010; Shao et al., 2006). It is also known that translocation of
Calpains to the plasma membrane usually correlates well with
enzyme activation. Crystal structure analysis in combination with
studies using calcium ionophore treatments in different cell lines
suggest a two-step model for Calpain activation. First, the inactive
cytoplasmic enzyme translocates to the plasma membrane in
response to increased intracellular Ca2þ levels and subsequently
it is activated in the presence of local Ca2þ and phospholipids (Gil-
Parrado et al., 2003; Michetti et al., 1996; Molinari et al., 1994;
Strobl et al., 2000; Suzuki et al., 2004). Indeed, it has been shown
that domain III of Calpain1 and 2 displays higher afﬁnity for
phospholipids in the presence of Ca2þ (Tompa et al., 2001). Our
results suggest that in addition to the regulation of its expression,
Calpain2 activation is also regulated both temporally and spatially
in the embryo. During gastrulation, Calpain2 localises at the
membrane in the dorsal mesoderm which is morphogenetically
active, while it is found in the cytosol (presumably inactive) in the
prospective neurectoderm. At neurula stages, Calpain2 becomes
membrane bound in the neurectoderm concomitantly with the
morphogenetic movements taking place in this tissue. Thus, there
is an overall correlation of Calpain2 activation with morphogen-
tically active tissues, in agreement with the role that Calpain2 has
in these processes based on the loss of function experiments.
A Calpain2 sensor similar to that described by Yang et al. (2011)
will be useful to study Calpain2 activation in vivo during gastrula-
tion and neurulation.
Several sources have reported the importance of calcium
signalling in the coordination of morphogenetic movements dur-
ing early vertebrate development. The existence of a calcium-
mediated pathway that is activated by some Wnt proteins (Wnt5a,
Wnt4 and Wnt11) has been described in both zebraﬁsh and
Xenopus (Slusarski et al., 1997a, 1997b) and it is known to induce
an increase in intracellular Ca2þ levels that in turn activate
calcium dependent enzymes like calcineurin, CamKII and PKC
(Kuhl et al., 2000a, 2000b; Sheldahl et al., 1999) thus modulating
different events during morphogenesis.
Furthermore, rhythmic calcium intercellular waves have been
observed in both Xenopus and in zebraﬁsh (Gilland et al., 1999;
Leclerc et al., 2006) and have been suggested to be a common
regulatory mechanism in vertebrates. Speciﬁcally, in Xenopus such
waves have been described in both dorsal mesoderm and neural
ectoderm of dorsal marginal zone explants (Wallingford et al.,
2001) as well as in intact embryos (Leclerc et al., 2000). These are
tissues known to be morphogenetically active and to undergo
convergent extension. Recent studies using a newly developed
GFP-based calcium probe, G-GECO, clearly showed dynamic ﬂuc-
tuations of intracellular calcium during neural tube closure (Ueno,
personal communication, 2012). It is still not known how the
waves are generated. It has been shown that the Wnt/Ca2þ is not
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responsible for their initiation, but it can only modulate their
frequency. Interestingly, embryos in which the calciumwaves have
been blocked by pharmacological treatment (Wallingford et al.,
2001) present phenotypes very similar to those we observed
following inhibition of Calpain activity.
Given the tight calcium-dependency of Calpains, we decided to
investigate if Calpain2 is activated through the non-canonical Wnt/
Ca2þ pathway. We showed that in response to ectopic expression of
Wnt5a, Calpain2 translocates to the plasma membrane, in agreement
with a previous study in which Wnt5a induces calpain activation and
stimulates axon growth in cortical neurons (Yang et al., 2011). We also
found that Calpain membrane localisation is dependent on Dsh, since
expression of Xdd1 blocks Calpain2 activation in the neural plate. This
is in agreement with a previous study that implicated Dsh in theWnt/
Ca2þ pathway by activating Ca2þ ﬂux, PKC and CamKII (Sheldahl et al.,
2003). Heterotrimeric G proteins are also known effectors of the Wnt/
Ca2þ signalling and inhibition of their function results in blockage of
PKC and CamKII membrane localisation (Sheldahl et al., 1999, 2003;
Slusarski et al., 1997a). The exact connection between G proteins and
Dsh is still unclear, although Dsh activation of the Wnt/Ca2þ pathway
was shown to be independent of G proteins ( Sheldahl et al., 2003). It
will be interesting to investigate if Calpain2 membrane localisation is
also mediated through G proteins.
Since overactivation of the non-canonical Wnt/Ca2þ pathway has
been shown to inhibit convergent extension movements, we decided
to test if this blockage was at least partially due to Calpain2 activation.
Indeed, expression of the dominant negative Calpain2 rescues the
Wnt5a blockage of convergent extension movements in animal cap
assays, suggesting that Wnt5a activates Calpain2 as one of the down-
stream effectors responsible for convergent extension blockage. Over-
all, we conclude that Calpain2 activity has to be precisely regulated
during convergent extension since both its inhibition and overactiva-
tion block this movement. This is not surprising since different
molecules involved in convergent extension movements are known
to lead to the same morphogenetic defect when overexpressed or
inhibited, indicating that their dose is absolutely crucial for proper
morphogenesis (Borchers et al., 2006; Djiane et al., 2000; Wallingford
and Harland, 2001; Wallingford et al., 2000).
It is possible that Calpain2 regulates mesoderm migration and
neural and mesoderm convergent extension by cleaving a set of
different substrates. Indeed several known Calpain substrates have
been implicated in the regulation of adhesion and motility of
different cell lines: protein kinases (PKC, FAK, and Src), phospha-
tases (calcineurin, PTP-1B), cytoskeleton-associated proteins (pax-
illin, α-actinin, and talin), adhesion molecules (β-integrins) and
regulatory proteins (RhoA) (Wells et al., 2005). The future chal-
lenge will be to identify speciﬁc Calpain2 substrates during
Xenopus development. A possible candidate substrate is calci-
neurin, since it has been shown that Calpain2 is able to cleave
and activate this protein in cultured neurons and in vivo in the
hippocampal region of mice during excitotoxic neurodegeneration
(Wu et al., 2004). Calcineurin is a phosphatase that upon activa-
tion through Wnt/Ca2þ pathway dephosphorilates NF-AT tran-
scription factor that can thus migrate into the nucleus and induce
transcription of genes that regulate convergent extension
(Borchers et al., 2006; Saneyoshi et al., 2002). It is thus possible
that Calpain2 could modulate convergent extension movement by
proteolytic cleavage of calcineurin. The phenotypes we observed
by blocking Calpain2 activity closely resemble those obtained by
inhibition/overactivation of NFAT (Borchers et al., 2006). Further-
more, it has been reported that Calpains are able to cleave
adhesion molecules in different cell lines (Benetti et al., 2005;
Jang et al., 2009; Rios-Doria et al., 2003). It is thus possible that
Calpains modulate Xenopus morphogenetic movements by affect-
ing cell–cell adhesion. However, our experiments using Keller
explants on ﬁbronectin seem to rule out this possibility as radial
intercalation is not affected by CI3 treatment, suggesting that
possible defects in junction remodelling (if present) are mild and
cannot account for the severe convergent extension defects.
A more intriguing possibility is that Calpain2 could modulate
the PCP pathway. Indeed, Calpain2 has been reported to cleave
RhoA in vitro and in cultured cells (Kulkarni et al., 2002). Our
experiment in CI3-treated DMZ explants shows a disruption of the
overall tissue polarity and impairment of cell–cell intercalation in
a similar fashion of explants in which the activity of members of
the PCP pathway have been altered (Tahinci and Symes, 2003;
Tahinci et al., 2007; Wallingford et al., 2000). Several studies have
suggested that Wnt/Ca2þ and PCP overlap at different levels in
terms of function and signalling mechanisms (Elul and Keller,
2000; Elul et al., 1997; Ezin et al., 2003; Sheldahl et al., 2003; Shih
and Keller, 1992a) although it is still not clear how the two
signalling pathways are integrated and coordinated to govern
cellular movements. It is possible that Calpain2 modulates the
cross-talk between the different Wnt pathways.
In conclusion, we have shown that Calpain2 is activated by the
Wnt5a pathway and, in agreement with its spatial and temporal
activation, it plays a role in mesoderm migration and mesoderm
and neural convergent extension. Future investigations of its
possible role in the modulation of Wnt/Ca2þ and PCP pathways
will bring new insight on the regulation of morphogenetic move-
ments during Xenopus gastrulation and neurulation.
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